Details for New Drug Application (NDA): 022369
✉ Email this page to a colleague
NDA 022369 describes LATISSE, which is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the LATISSE profile page.
The generic ingredient in LATISSE is bimatoprost. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.
The generic ingredient in LATISSE is bimatoprost. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bimatoprost profile page.
Summary for 022369
| Tradename: | LATISSE |
| Applicant: | Abbvie |
| Ingredient: | bimatoprost |
| Patents: | 1 |
Suppliers and Packaging for NDA: 022369
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369 | NDA | Allergan, Inc. | 0023-3616 | 0023-3616-05 | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-05) / 5 mL in 1 BOTTLE, DROPPER |
| LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369 | NDA | Allergan, Inc. | 0023-3616 | 0023-3616-70 | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-70) / 3 mL in 1 BOTTLE, DROPPER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;TOPICAL | Strength | 0.03% | ||||
| Approval Date: | Dec 24, 2008 | TE: | AT | RLD: | Yes | ||||
| Patent: | ⤷ Sign Up | Patent Expiration: | May 25, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | METHOD OF INCREASING HAIR GROWTH | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | May 25, 2024 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | METHOD OF STIMULATING HAIR GROWTH | ||||||||
Expired US Patents for NDA 022369
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | LATISSE | bimatoprost | SOLUTION/DROPS;TOPICAL | 022369-001 | Dec 24, 2008 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
